Elizabeth Parada Sánchez

Elizabeth Parada Sánchez

Auto-generated profile, based on publicly available information

Elizabeth Parada Sánchez

Hospital Vargas de Caracas

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
DSDra. Elizabeth Parada Sánchez
Dra. Elizabeth Parada Sánchez
La dermatitis atópica pediátrica es una enfermedad inflamatoria crónica asociada con disfunción de la barrera epidérmica, alteraciones inmunológicas y disbiosis del microbioma cutáneo. Aunque los emolientes constituyen la base del cuidado tópico, su capacidad para modificar los componentes microbiológicos de la enfermedad es limitada, lo que ha impulsado el estudio de probióticos, postbióticos y bioterapéuticos tópicos. El objetivo de esta revisión sistemática fue evaluar la eficacia y seguridad de las intervenciones tópicas dirigidas al microbioma frente a los emolientes estándar para mejorar la función de la barrera en pacientes pediátricos con dermatitis atópica. Se realizó una búsqueda estructurada en bases de datos biomédicas, seleccionándose 20 publicaciones verificadas: ocho sobre intervenciones dirigidas al microbioma, ocho relacionadas con emolientes y función de la barrera y cuatro documentos de contextualización. Se analizaron gravedad clínica, pérdida transepidérmica de agua, hidratación, xerosis, prurito, colonización por Staphylococcus aureus, utilización de corticosteroides y eventos adversos. Los estudios sobre Roseomonas mucosa, Lactobacillus johnsonii y Vitreoscilla filiformis mostraron resultados prometedores en la reducción de la gravedad clínica, la colonización por S. aureus y algunos indicadores de reparación epitelial. Sin embargo, los hallazgos fueron heterogéneos y un ensayo controlado de FB-401 no demostró superioridad frente al placebo. Los emolientes presentaron evidencia más consistente para mejorar la hidratación y reducir la pérdida de agua, aunque sus efectos variaron según la formulación. No fue posible realizar un metaanálisis debido a la heterogeneidad de las intervenciones y desenlaces. La evidencia disponible no permite afirmar que los probióticos tópicos sean superiores a los emolientes estándar. Estas intervenciones deben considerarse estrategias complementarias y todavía requieren ensayos pediátricos aleatorizados, comparaciones activas y mediciones estandarizadas de la función de la barrera.

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
juan jose valerojuan jose valero
juan jose valero
GLGuillermo Andres Díaz León
Guillermo Andres Díaz León
ASAndrés Ricardo Arévalo Sánchez
Andrés Ricardo Arévalo Sánchez
AFAna María Bautista Forero
Ana María Bautista Forero
ESElizabeth Parada Sánchez
Elizabeth Parada Sánchez
GUGissele Stephanie Verdezoto Unaucho
Gissele Stephanie Verdezoto Unaucho
Vestibular schwannoma presents a significant challenge in contemporary skull base surgery due to the complex balance between tumor control and the preservation of auditory and neurological function. This narrative review examines current scientific evidence regarding hearing preservation, intraoperative neurophysiological monitoring, and microsurgical strategies, incorporating international clinical research, systematic reviews, meta-analyses, and evidence-based guidelines—including contributions from Latin America. The analysis considers preoperative auditory characteristics, tumor dimensions, the selection of surgical approach, electrophysiological monitoring, and long-term functional outcomes. Comparative evidence indicates that the retrosigmoid and middle cranial fossa approaches yield different outcomes depending on the size and anatomical extent of the tumor, with no universal superiority established for either technique. Auditory brainstem responses and direct monitoring of the cochlear nerve provide complementary data on neural integrity during microsurgical manipulation, although evidence supporting the superiority of using these methods in combination remains insufficient. Longitudinal findings show a progressive decline in functional hearing preservation across observation, stereotactic radiosurgery, and microsurgical treatment. Nevertheless, patients who retain functional hearing immediately following surgery may maintain favorable outcomes during long-term follow-up. Methodological differences across studies limit direct comparisons. These findings underscore the necessity for individualized surgical planning, comprehensive preoperative assessment, microsurgical techniques focused on functional preservation, and the accurate interpretation of electrophysiological data. Prospective, multicenter studies—with greater participation from Latin America—are required to standardize functional outcome reporting, strengthen comparative evidence, and optimize both hearing preservation and quality of life.

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
LHLuis Alberto Erosa-De Haro
Luis Alberto Erosa-De Haro
CFCamilo José Izquierdo Flores
Camilo José Izquierdo Flores
EOEber Marcel Mendoza Osorio
Eber Marcel Mendoza Osorio
JSJuan José Vergara Serpa
Juan José Vergara Serpa
AMAlvaro Enrique Marroquin Murcia
Alvaro Enrique Marroquin Murcia
TSTatiana Isabel Panqueva Sánchez
Tatiana Isabel Panqueva Sánchez
Neurodevelopmental disorders represent a heterogeneous group of conditions characterized by alterations in cognitive, behavioral, motor, and neurological development, frequently associated with complex genetic mechanisms. Among these, de novo genetic variants have emerged as major contributors to severe developmental phenotypes, including intellectual disability, global developmental delay, autism spectrum disorder, and developmental epileptic encephalopathies. This review examines the molecular contribution of newly arising genetic variants, the diagnostic performance of next-generation sequencing technologies, genotype–phenotype correlations, and the clinical implications of early molecular identification. A structured narrative review was developed using 20 foundational and contemporary scientific publications, complemented by recent evidence concerning clinical utility, with particular attention to international investigations and Latin American contributions. The reviewed evidence indicates that pathogenic de novo coding variants account for an estimated 42% of severe developmental disorders in a major genomic cohort, while exome sequencing demonstrates an overall diagnostic yield of approximately 36% across neurodevelopmental populations. Evidence from Brazil further illustrates the relevance of newly arising variants in genetically heterogeneous pediatric cohorts. Molecular findings reveal convergence among genes involved in chromatin remodeling, transcriptional regulation, synaptic organization, and neuronal excitability, highlighting the complexity of genotype–phenotype relationships. Furthermore, positive genomic diagnoses may contribute to modifications in clinical management, although improvements in long-term developmental outcomes remain insufficiently established. Persistent challenges include uncertain variant classification, incomplete molecular characterization, unequal population representation, and limited access to genomic technologies. The integration of genomic sequencing, comprehensive clinical phenotyping, genetic counseling, and multidisciplinary pediatric care constitutes a fundamental strategy for improving etiological diagnosis and supporting individualized management. Expanded international collaboration and longitudinal research are necessary to strengthen clinical translation and equitable access to precision genomic medicine.

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
JSJuan José Vergara Serpa
Juan José Vergara Serpa
MAMaría José Peñafiel Aguirre
María José Peñafiel Aguirre
JCJavier Emanuel Camacho-Patiño
Javier Emanuel Camacho-Patiño
VMVelbeth Elizabeth Recinos Martínez
Velbeth Elizabeth Recinos Martínez
ESElizabeth Parada Sánchez
Elizabeth Parada Sánchez
DQDiva Dalesska Herrería Quiñónez
Diva Dalesska Herrería Quiñónez
Chronic pruritus is a multifactorial clinical condition characterized by persistent itching and complex interactions among immune signaling, neuronal sensitization, psychological disturbances, and behavioral responses. Its clinical significance extends beyond cutaneous manifestations, frequently affecting sleep quality, emotional well-being, daily functioning, and overall quality of life. This narrative review aimed to analyze the neuroimmune mechanisms underlying chronic pruritus, examine its relationship with psychiatric comorbidities, and evaluate current multimodal therapeutic strategies from an international perspective, incorporating scientific contributions from Latin America. A qualitative, descriptive, and analytical approach was adopted to synthesize evidence from experimental investigations, observational studies, clinical trials, and international guidelines. The reviewed literature identified IL-4, IL-13, IL-31, and thymic stromal lymphopoietin as relevant mediators of neuroimmune communication, with signaling pathways involving JAK1, TRPV1, and TRPA1 contributing to sensory neuronal activation and hypersensitivity. Peripheral and central sensitization were associated with persistent sensory amplification and maintenance of the itch–scratch cycle. Psychiatric findings demonstrated clinically relevant associations with anxiety, depression, psychological stress, and sleep disturbances, although causal relationships remain incompletely established. Randomized clinical trials showed meaningful reductions in itch intensity following targeted inhibition of IL-4/IL-13 and IL-31 receptor signaling in patients with prurigo nodularis. Latin American evidence highlighted substantial symptom burden, quality-of-life impairment, and regional limitations in access to specialized healthcare. Overall, the findings support understanding chronic pruritus as a multidimensional condition requiring individualized assessment and coordinated dermatological, neurological, and psychological approaches. Further longitudinal and comparative investigations are necessary to clarify neuroimmune biomarkers, establish the clinical relevance of central sensitization, and determine the effectiveness of integrated multimodal interventions across different pruritic disorders.